SOPHiA GENETICS SA (SOPH) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on SOPHiA GENETICS SA (SOPH) is Neutral.

The composite score behind that read is -0.01, weighing +0.08 of bullish evidence against -0.16 bearish.

SOPHiA GENETICS SA last closed at $8.20, +1.61% on the session.

Against the IVW growth benchmark the position is +0.69% over the forecast window.

The read is built from 12 underlying insights — 7 bullish and 5 bearish.

Agreement across those insights is 42%.

2 graded predictions for SOPH so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks SOPHiA GENETICS SA in the 8th percentile on return on equity, where 100 is best.

SOPHiA GENETICS SA is classified under Health Care / Health Care Technology, with a market capitalisation of $686.98M.

StockMap tracks SOPHiA GENETICS SA as the 10th largest of the 18 companies it covers in the Health Care Technology industry, part of the Health Care sector.

Across that group the current two-week reads are 12 Neutral and 6 Moderate Underperform.

On that composite SOPHiA GENETICS SA ranks 4th of 18 in the group, against a group median of -0.10.